Gene variations may predict response to breast cancer prevention therapies

The following is an edited excerpt.

Researchers from the Mayo Clinic in Minnesota have identified variants in two genes that result in a higher chance that prophylactic therapy, using the drugs tamoxifen or raloxifene, will actually prevent breast cancer in high risk women. More studies are needed, but if confirmed, women with these variants may be more likely to undergo the 5 year preventive regimen.

Read the full story here: Gene Variations May Predict Response to Breast Cancer Prevention Therapies

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend